FDA confirms Class I recall for vascular device used by cardiologists and surgeons - Cardiovascular Business
Cardiovascular Business reports the FDA has confirmed a Class I recall — the agency's most serious designation, reserved for products where use may cause serious injury or death — affecting a vascular device used by cardiologists and surgeons.
The underlying source notification was not provided in detail here, so the specific device, manufacturer, defect mode, and affected lot numbers are not characterized in the material available.
Class I recalls in the vascular and structural heart space have historically involved closure devices, sheaths, delivery systems, and access-site hemostasis products — categories with direct relevance to TAVR, TEER, and TTVR workflows where large-bore access and vascular complications drive morbidity.
Without device-specific details, the operational guidance is generic: programs should ensure their materials management and recall tracking systems are functioning, confirm whether affected inventory is in use, and review recent cases for any signal consistent with the recall mechanism.
FDA confirms Class I recall for vascular device used by cardiologists and surgeons Cardiovascular Business
- Aortic Valve (TAVR/TAVI)· Giornale italiano di cardiologia (2006)[Ventricular tachycardia and left bundle branch block after transcatheter aortic valve implantation: is the valve guilty forever or not?].
- Aortic Valve (TAVR/TAVI)· American heart journal plus : cardiology research and practiceClinical outcomes following transcatheter aortic valve replacement in patients with concordant versus discordant aortic stenosis.
- Aortic Valve (TAVR/TAVI)· CureusAssociation of Comorbidity Burden With In-Hospital Mortality in Transcatheter Aortic Valve Replacement Patients With Coexisting Malignancy in the United States: A Retrospective Cohort Study.
